Pages that link to "Q46769254"

The following pages link to Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice (Q46769254):

Displaying 27 items.

• Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach (Q24863741) (← links)
• Analysis of immune responses against H pylori in rabbits (Q33787949) (← links)
• Immunogenicity of Recombinant Helicobacter pylori Urease B Administered by Various Routes and with Different Adjuvants (Q33996971) (← links)
• Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection (Q34099129) (← links)
• Immunization with Heat Shock Protein A and γ-Glutamyl Transpeptidase Induces Reduction on the Helicobacter pylori Colonization in Mice (Q35671658) (← links)
• Effect of Different Adjuvants on Protection and Side-Effects Induced by Helicobacter suis Whole-Cell Lysate Vaccination. (Q35675819) (← links)
• Defining the Roles of IFN-γ and IL-17A in Inflammation and Protection against Helicobacter pylori Infection. (Q35689712) (← links)
• Role of Peyer's patches in the induction of Helicobacter pylori-induced gastritis. (Q35829163) (← links)
• Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations. (Q35913554) (← links)
• Therapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection. (Q35914868) (← links)
• Inflammation, immunity, vaccines for Helicobacter infection (Q36573978) (← links)
• Progress in vaccine development against Helicobacter pylori (Q36794861) (← links)
• A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection (Q36826907) (← links)
• A critical evaluation of the evidence on a causal relationship between Helicobacter pylori and otitis media with effusion (Q37013172) (← links)
• Antibody Production and Th1-biased Response Induced by an Epitope Vaccine Composed of Cholera Toxin B Unit and Helicobacter pylori Lpp20 Epitopes (Q39177569) (← links)
• Association between Helicobacter pylori and intestinal parasites in an Añu indigenous community of Venezuela (Q40690374) (← links)
• Therapeutic efficacy of the multi-epitope vaccine CTB-UE against Helicobacter pylori infection in a Mongolian gerbil model and its microRNA-155-associated immuno-protective mechanism (Q42203128) (← links)
• Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model. (Q44532534) (← links)
• The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice (Q46734851) (← links)
• Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model (Q47788853) (← links)
• Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model (Q50040740) (← links)
• Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit (Q54347312) (← links)
• A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori (Q82831287) (← links)
• Recombinant Mycobacterium smegmatis mc(2)155 vaccine expressing outer membrane protein 26 kDa antigen affords therapeutic protection against Helicobacter pylori infection (Q83102402) (← links)
• Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant (Q91010286) (← links)
• Synthetic Lipopeptide Enhances Protective Immunity Against Helicobacter pylori Infection (Q93147503) (← links)
• Outer Membrane Vesicles of Helicobacter pylori 7.13 as Adjuvants Promote Protective Efficacy Against Helicobacter pylori Infection (Q98177590) (← links)